Titel

Merkliste
1 Ergebnisse

Dupilumab shows long-term safety and efficacy in patients w..:

Deleuran, Mette ; Thaçi, Diamant ; Beck, Lisa A...
https://pure.au.dk/portal/da/publications/dupilumab-shows-longterm-safety-and-efficacy-in-patients-with-moderate-to-severe-atopic-dermatitis-enrolled-in-a-phase-3-openlabel-extension-study(7ba7b7fc-2da2-4ed5-8857-cd425ba5c646).html. , 2020

Link: https://pure.au.dk/portal/da/publications/dupilumab-sh..

RT Journal
T1 <Title>Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension study</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftuniaarhuspubl:oai:pure.atira.dk:publications_7ba7b7fc-2da2-4ed5-8857-cd425ba5c646&Exemplar=1&LAN=DE
				
A1 Deleuran, Mette
A1 Thaçi, Diamant
A1 Beck, Lisa A
A1 de Bruin-Weller, Marjolein
A1 Blauvelt, Andrew
A1 Forman, Seth
A1 Bissonnette, Robert
A1 Reich, Kristian
A1 Soong, Weily
A1 Hussain, Iftikhar
A1 Foley, Peter
A1 Hide, Michihiro
A1 Bouaziz, Jean David
A1 Gelfand, Joel M
A1 Sher, Lawrence
A1 Schuttelaar, Marie L.A
A1 Wang, Chen
A1 Chen, Zhen
A1 Akinlade, Bolanle
A1 Gadkari, Abhijit
A1 Eckert, Laurent
A1 Davis, John D
A1 Rajadhyaksha, Manoj
A1 Staudinger, Heribert
A1 Graham, Neil M.H
A1 Pirozzi, Gianluca
A1 Ardeleanu, Marius
YR 2020
K1 atopic dermatitis
K1 biologic therapy
K1 dupilumab
K1 efficacy
K1 IL-13
K1 IL-4
K1 long-term
K1 monoclonal antibody
K1 open label
K1 quality of life
K1 safety
JF https://pure.au.dk/portal/da/publications/dupilumab-shows-longterm-safety-and-efficacy-in-patients-with-moderate-to-severe-atopic-dermatitis-enrolled-in-a-phase-3-openlabel-extension-study(7ba7b7fc-2da2-4ed5-8857-cd425ba5c646).html
LK http://dx.doi.org/https://pure.au.dk/portal/da/publications/dupilumab-shows-longterm-safety-and-efficacy-in-patients-with-moderate-to-severe-atopic-dermatitis-enrolled-in-a-phase-3-openlabel-extension-study(7ba7b7fc-2da2-4ed5-8857-cd425ba5c646).html
DO https://pure.au.dk/portal/da/publications/dupilumab-shows-longterm-safety-and-efficacy-in-patients-with-moderate-to-severe-atopic-dermatitis-enrolled-in-a-phase-3-openlabel-extension-study(7ba7b7fc-2da2-4ed5-8857-cd425ba5c646).html
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)